Skip to main content
# Title Department Research Member Research Year
491 Preemptive nebulized ketamine for pain control after tonsillectomy in children: randomized controlled trial Department of Anesthesia, Intensive care and Pain management Dr. Amira Mahmoud Mohammed Osman 2019
492 Dexmedetomidine versus midazolam as an adjuvant sedating agent for bone marrow aspiration in pediatric patients. Department of Anesthesia, Intensive care and Pain management Mohamed Hussein Mahmoud Ahmed 2019
493 Prognostic Significance of Absolute
Lymphocytic Count Recovery in Pediatric
Patients with Acute Lymphoblastic Leukemia at
South Egypt Cancer Institute
Department of Pediatric Oncology Dr. Azaa Shibl Sayed Mahmoud 2019
494 Prognostic Value of Telomere Length in Peripheral Blood Leucocytes in Breast Cancer Patients (South Egypt Cancer Institute Experience) Department of Clinical Pathology Dr. Abeer Mostafa Mostafa Darwish 2019
495 Prognostic Significance of Absolute
Lymphocytic Count Recovery in Pediatric
Patients with Acute Lymphoblastic Leukemia at
South Egypt Cancer Institute
Department of Clinical Pathology Dr. Noha gaber sayed 2019
496 Assesment OF complement regulatory protients CD55 and CD59 on erythocytes in Betathalassemia major patients Department of Clinical Pathology Dr. Iman Hassan Ahmed Hamada 2019
497 Circulating hematopoietic stem cells, endothelial
progenitor cells and cancer stem cells in
hepatocellular carcinoma patients: contribution to
diagnosis and prognosis
Department of Medical Oncology Dr. Ahmed Refaat Abdel Zaher Mubarak 2019
498 Immunohistochemical study of folate receptor-α and mammalian
target of rapamycin in endometrial hyperplasia and
endometrioid endometrial carcinoma


Department of Radiotherapy and Nuclear medicine Dr. Asmaa elsayed abdelsalam /hasaballah 2019
499 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2019
500 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2019